Effect of Anticoagulation in Reducing the Incidence of Splenic/Portal Vein Thrombosis Post-Laparoscopic Splenectomy Protocol Number: 5698.

Trial Profile

Effect of Anticoagulation in Reducing the Incidence of Splenic/Portal Vein Thrombosis Post-Laparoscopic Splenectomy Protocol Number: 5698.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 01 Aug 2011

At a glance

  • Drugs Enoxaparin sodium (Primary)
  • Indications Venous thrombosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 26 Jun 2009 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov
    • 26 Jun 2009 Actual number of patients (35) added as reported by ClinicalTrials.gov.
    • 23 Oct 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top